**Question:** A patient who had a history of hepatitis one month ago should preferably given which local anaesthetic agent?

**Core Concept:** Hepatitis is an inflammation of the liver caused by viruses or other factors, which can affect the liver's ability to produce and process drugs. When administering local anaesthetics to hepatitis patients, it is essential to consider potential drug interactions, reduced drug clearance, and the risk of liver toxicity.

**Why the Correct Answer is Right:**

Correct Answer: D. Eucaine (Bupivacaine)

**Why Each Wrong Option is Incorrect:**

A. Lidocaine: Lidocaine is primarily cleared by the liver and kidneys. In hepatitis patients, this clearance may be reduced, leading to higher plasma concentrations and potential toxicity.

B. Bupivacaine: Bupivacaine is primarily cleared by the liver and kidneys. Similar to lidocaine, its use in hepatitis patients may result in higher plasma concentrations and toxicity.

C. Levobupivacaine: Levobupivacaine is a S-enantiomer of bupivacaine and shares similar pharmacokinetic properties. Like lidocaine and bupivacaine, its use in hepatitis patients could lead to toxicity due to reduced clearance.

D. Eucaine (Bupivacaine): Eucaine is a prodrug of bupivacaine, which is converted to bupivacaine in the liver. Although it is theoretically safer regarding potential drug interactions, it remains essential to consider reduced clearance in hepatitis patients, potentially leading to higher plasma concentrations and toxicity.

**Why the Correct Answer is Right:**

Eucaine (Bupivacaine) is chosen as the correct answer due to its role as a prodrug that is converted to the active bupivacaine in the liver. Unlike lidocaine, bupivacaine, and levobupivacaine, the liver plays a crucial role in its activation, reducing the risk of potential drug interactions. However, it is essential to consider the reduced clearance in hepatitis patients, which may lead to higher plasma concentrations and toxicity.

**Clinical Pearl:** When administering local anaesthetics to hepatitis patients, consider potential drug interactions, reduced clearance, and increased risk of toxicity. Always consult with a physician before administering local anaesthetics to these patients.

**Why Each Wrong Option is Incorrect:**

Lidocaine, bupivacaine, and levobupivacaine are active drugs, and their use in hepatitis patients may result in higher plasma concentrations due to reduced clearance, increasing the risk of toxicity.